Quince Therapeutics, Inc. (QNCX)

NASDAQ: QNCX · IEX Real-Time Price · USD
2.34
-0.03 (-1.27%)
At close: Aug 12, 2022 4:00 PM
2.42
+0.08 (3.42%)
After-hours: Aug 12, 2022 6:54 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20212020201920182017
Selling, General & Admin
29.5217.598.952.031.27
Research & Development
60.861.3130.2110.099.1
Other Operating Expenses
0.250000
Operating Expenses
90.5778.8939.1712.1210.37
Operating Income
-90.57-78.89-39.17-12.12-10.37
Interest Expense / Income
0000.961.64
Other Expense / Income
-0.62-2.04-2.19-0.60.22
Pretax Income
-89.95-76.85-36.98-12.48-12.24
Net Income
-89.95-76.85-36.98-12.48-12.24
Net Income Common
-89.95-76.85-36.98-12.48-12.24
Shares Outstanding (Basic)
30291933
Shares Outstanding (Diluted)
30291933
Shares Change
1.86%53.30%466.06%1.79%-
EPS (Basic)
-3.03-2.63-1.94-3.71-3.70
EPS (Diluted)
-3.03-2.63-1.94-3.71-3.70
Free Cash Flow Per Share
-2.12-1.74-1.75-3.54-3.00
EBITDA
-89.6-76.52-36.79-11.47-10.55
Depreciation & Amortization
0.340.330.190.050.05
EBIT
-89.95-76.85-36.98-11.52-10.59
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).